"Membrane Glycoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycoproteins found on the membrane or surface of cells.
Descriptor ID |
D008562
|
MeSH Number(s) |
D12.776.395.550 D12.776.543.550
|
Concept/Terms |
Membrane Glycoproteins- Membrane Glycoproteins
- Glycoproteins, Membrane
- Cell Surface Glycoproteins
- Glycoproteins, Cell Surface
- Surface Glycoproteins, Cell
- Cell Surface Glycoprotein
- Glycoprotein, Cell Surface
- Surface Glycoprotein, Cell
- Surface Glycoproteins
- Glycoproteins, Surface
- Surface Glycoprotein
- Glycoprotein, Surface
- Membrane Glycoprotein
- Glycoprotein, Membrane
|
Below are MeSH descriptors whose meaning is more general than "Membrane Glycoproteins".
Below are MeSH descriptors whose meaning is more specific than "Membrane Glycoproteins".
This graph shows the total number of publications written about "Membrane Glycoproteins" by people in this website by year, and whether "Membrane Glycoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 5 | 1 | 6 |
1996 | 6 | 1 | 7 |
1997 | 5 | 1 | 6 |
1998 | 10 | 5 | 15 |
1999 | 10 | 5 | 15 |
2000 | 15 | 4 | 19 |
2001 | 11 | 3 | 14 |
2002 | 12 | 7 | 19 |
2003 | 8 | 7 | 15 |
2004 | 7 | 10 | 17 |
2005 | 8 | 13 | 21 |
2006 | 6 | 2 | 8 |
2007 | 6 | 2 | 8 |
2008 | 5 | 4 | 9 |
2009 | 5 | 5 | 10 |
2010 | 7 | 4 | 11 |
2011 | 3 | 2 | 5 |
2012 | 4 | 6 | 10 |
2013 | 9 | 4 | 13 |
2014 | 3 | 5 | 8 |
2015 | 2 | 0 | 2 |
2016 | 6 | 2 | 8 |
2017 | 5 | 3 | 8 |
2018 | 3 | 2 | 5 |
2019 | 3 | 0 | 3 |
2020 | 2 | 5 | 7 |
2021 | 6 | 3 | 9 |
2022 | 0 | 3 | 3 |
2023 | 1 | 4 | 5 |
2024 | 1 | 3 | 4 |
2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Membrane Glycoproteins" by people in Profiles.
-
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions. Clin Cancer Res. 2025 Feb 03; 31(3):561-572.
-
Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression. Cancer Res Commun. 2024 12 01; 4(12):3209-3223.
-
Phase I dose escalation study of IO-108, an anti-LILRB2 antibody, in patients with advanced solid tumors. J Immunother Cancer. 2024 Nov 20; 12(11).
-
Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy. Cell Rep. 2024 Nov 26; 43(11):114875.
-
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer. Cancer Res Commun. 2024 09 01; 4(9):2444-2453.
-
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy. Nature. 2024 Aug; 632(8023):182-191.
-
Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression. Neuropsychopharmacology. 2024 Nov; 50(1):153-163.
-
Rare Variant in MRC2 Associated With Familial Supraventricular Tachycardia and Wolff-Parkinson-White Syndrome. Circ Genom Precis Med. 2024 Aug; 17(4):e004614.
-
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma. Neuro Oncol. 2024 05 03; 26(5):826-839.
-
Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor. Mod Pathol. 2024 Mar; 37(3):100426.